Workflow
股东诉讼
icon
Search documents
马斯克成为史上首位身家超7000亿美元富豪
Sou Hu Cai Jing· 2025-12-22 05:36
在成为全球首位身家突破6000亿美元的富豪仅数日后,特斯拉CEO埃隆·马斯克再度刷新财富纪录,成 为全球首位身家超过7000亿美元的个人。 图片来源:视觉中国 当地时间12月21日,据《福布斯》实时亿万富豪榜,马斯克个人净资产飙升至7490亿美元(约合5.28万 亿元人民币)。 马斯克财富再度暴涨,主要是因为一项搁置多年的薪酬方案得以恢复。 但马斯克最终带领特斯拉一步步实现了所有目标。然而一位特斯拉小股东理查德·托内塔(Richard Tornetta)在2022年对此提起诉讼。2024年1月,美国特拉华州衡平法院法官裁定该薪酬方案无效,原因 是特斯拉公司董事会未能证明"薪酬计划是公平的"。 据智通财经,为防范今后类似股东诉讼,特斯拉甚至将公司注册地从美国特拉华州迁至得克萨斯州,并 依据得州法律设定条款,限制持股比例不足3%的投资方起诉公司。 上周早些时候,马斯克刚成为史上首个净资产超过6000亿美元的个人。12月10日马斯克在社交媒体平台 X上暗示SpaceX可能IPO,此前有报道称这家火箭制造商可能在2026年上市。据彭博财富指数,马斯克 持有SpaceX大约42%的股权。12月17日,据报道,Space ...
Kuehn Law Encourages Investors of Petco Health and Wellness Company, Inc. to Contact Law Firm
Prnewswire· 2025-09-24 18:10
Core Viewpoint - Kuehn Law is investigating potential breaches of fiduciary duties by officers and directors of Petco Health and Wellness Company, Inc. related to misrepresentation of the company's business model and performance during the pandemic [1]. Summary by Relevant Sections - **Fiduciary Duties Investigation** - Kuehn Law is examining whether certain insiders at Petco misrepresented or failed to disclose critical information regarding the sustainability of the company's pandemic-related growth and its business model focused on premium pet food [1]. - **Misrepresentation of Business Performance** - The investigation highlights that insiders allegedly overstated the strength of Petco's differentiated product strategy and downplayed the severity of issues affecting the company's performance [1]. - **Impact on Financial Statements** - The lawsuit claims that public statements made by Petco were materially false and misleading, affecting the perception of the company's ability to achieve sustainable and profitable growth [1].
Peloton必须面对股东关于疫情期间库存声明的诉讼
Ge Long Hui A P P· 2025-08-28 02:40
Core Viewpoint - Peloton Interactive is required to face a lawsuit alleging that it misled shareholders by concealing excess inventory of home fitness equipment during the easing of COVID-19 restrictions, as ruled by the federal appeals court [1] Summary by Relevant Sections - **Lawsuit Details** - The Manhattan Second Circuit Court overturned a lower court's decision, allowing shareholders to continue their claims against Peloton [1] - The lawsuit claims that Peloton made three false and misleading statements that artificially inflated its stock price [1] - **Stock Performance Context** - The shareholder lawsuit coincides with a period when Peloton's stock price plummeted over 80% from February 5, 2021, to January 19, 2022 [1] - This decline in stock price aligns with the widespread availability of vaccines and the reopening of gyms [1]
UnitedHealth concealed how backlash from CEO Brian Thompson's killing was hurting profit: shareholder lawsuit
New York Post· 2025-05-07 20:45
Core Viewpoint - UnitedHealth Group is facing a lawsuit for allegedly concealing the negative impact of the killing of its CEO on its business, which led to a significant drop in its stock price after a lowered 2025 profit outlook [1][2]. Group 1: Lawsuit Details - A proposed class action was filed in Manhattan federal court, claiming that shareholders were defrauded following the December 4 shooting of CEO Brian Thompson [2]. - The lawsuit seeks unspecified damages for shareholders from December 3, 2024, to April 16, 2025, with CEO Andrew Witty and CFO John Rex also named as defendants [5]. Group 2: Stock Performance and Financial Impact - UnitedHealth shares plummeted by 22% on April 17, resulting in a loss of approximately $119 billion in market value after the company revised its 2025 adjusted profit per share forecast down to between $26 and $26.50 from a previous range of $29.50 to $30 [3][4]. - The company attributed the lowered forecast to increased costs in its Medicare business, having issued the prior forecast just one day before Thompson's death [4]. Group 3: Allegations of Misleading Information - Shareholders allege that UnitedHealth inflated its stock price by maintaining its old forecast despite growing public backlash and a Senate report on claims denials, which pressured the company to adopt more patient-friendly practices [4][10].